Literature DB >> 5507671

Decarboxylation of 3,4-dihydroxyphenylalanine in various human adult and fetal tissues.

W H Vogel, H McFarland, L N Prince.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5507671     DOI： 10.1016/0006-2952(70)90220-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  4 in total

Review 1.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

2.  Effects of pyridoxal phosphate and L-dopapyridoxal phosphate on DOPA decarboxylase activity.

Authors:  N Tran
Journal:  Experientia       Date:  1972-09-15

3.  Blood and urine 5-hydroxytryptophan and 5-hydroxytryptamine levels after administration of two 5-hydroxytryptamine precursors in normal man.

Authors:  T C Wa; N J Burns; B C Williams; S Freestone; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

4.  Decrease of the 3,4-dihydroxyphenylalanine (DOPA) decarboxylase activities in human erythrocytes and mouse tissues after administration of DOPA.

Authors:  S S Tate; R Sweet; F H McDowell; A Meister
Journal:  Proc Natl Acad Sci U S A       Date:  1971-09       Impact factor: 11.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.